The glymphatic system as a brain scavenger in Alzheimer’s disease: mechanisms and therapeutic implications
Brain Research · 2026
DOI: 10.1016/j.brainres.2026.150221 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain Research, 2026. Verfasst von Manyv Zheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin 300193, China. Electronic address: zmanyv@163.com. Hauptthemen laut MEDLINE: Alzheimer Disease, Glymphatic System, Brain. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 158 Literaturangaben. Gefördert von: National Administration of Traditional Chinese Medicine.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD), the most common neurodegenerative disorder worldwide, is increasingly recognized as a major threat to global health. Its pathogenesis remains highly complex, and effective treatments are still lacking. Recent research, however, has identified a crucial player in this process-the glymphatic system, which acts as a metabolic "scavenger" in the brain, responsible for clearing waste products such as amyloid-β (Aβ) and hyperphosphorylated tau protein. Impairment of this system leads to the accumulation of these toxic proteins, which are hallmark pathological features of AD. This review comprehensively examines how glymphatic dysfunction contributes to the aggregation of Aβ and tau, thereby driving AD progression. Astrocytes regulate fluid transport via aquaporin-4 (AQP4) water channels, while microglia modulate glymphatic efficiency through phagocytosis and neuroinflammatory signaling. These cells work in concert to maintain brain homeostasis. However, in AD, the loss of polarized AQP4 expression in astrocytes, obstruction of cerebrospinal-interstitial fluid exchange by Aβ and tau, and dysregulated microglial activation collectively accelerate disease pathology. Advances in diagnostic biomarkers-such as Aβ/tau PET imaging and CSF profiles of GFAP/sTREM2-offer promising avenues for early AD detection. Meanwhile, therapeutic strategies targeting glymphatic-astrocyte-microglia interactions, including AQP4 enhancers, TREM2 agonists, and anti-inflammatory agents, open new possibilities for treatment. By integrating insights from preclinical and clinical studies, this review underscores the vital role of the glymphatic system in early intervention, highlighting potential approaches to slow AD progression through enhanced waste clearance and immunomodulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin 300193, China. Electronic address: zmanyv@163.com.
- School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin 300193, China. Electronic address: wenyasu1996@126.com.
- School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin 300193, China. Electronic address: luyaotian1999@163.com.
- School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin 300193, China. Electronic address: pharmgao@tju.edu.cn.
Förderung
- National Administration of Traditional Chinese Medicine
Zitieren
APA
Zheng, M., Su, W., Tian, L., & Gao, W. (2026). The glymphatic system as a brain scavenger in Alzheimer’s disease: mechanisms and therapeutic implications. Brain Research. https://doi.org/10.1016/j.brainres.2026.150221
Vancouver
Zheng M, Su W, Tian L, Gao W. The glymphatic system as a brain scavenger in Alzheimer’s disease: mechanisms and therapeutic implications. Brain Research. 2026. doi:10.1016/j.brainres.2026.150221
BibTeX
@article{Zheng2026,
author = {Zheng, Manyv and Su, Wenya and Tian, Luyao and Gao, Wenyuan},
title = {The glymphatic system as a brain scavenger in Alzheimer’s disease: mechanisms and therapeutic implications},
journal = {Brain Research},
year = {2026},
doi = {10.1016/j.brainres.2026.150221}
}
EUVIMED